Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version of the company's Luvox CR anti-depressant by Par Pharmaceutical. Additionally, Kohlberg Kravis Roberts (KKR) confirnms that it sold around 3.73M shares late last week at $58.28 each for $218.5M in gross proceeds, reducing its stake to around 6.5%.